Bristol-Myers Squibb Company (FRA:BRM)
40.38
+0.89 (2.24%)
Last updated: Sep 9, 2025, 9:00 AM CET
FRA:BRM Revenue
Bristol-Myers Squibb Company had revenue of $12.27B USD in the quarter ending June 30, 2025, with 0.56% growth. This brings the company's revenue in the last twelve months to $47.70B, up 2.57% year-over-year. In the year 2024, Bristol-Myers Squibb Company had annual revenue of $48.30B with 7.32% growth.
Revenue (ttm)
$47.70B
Revenue Growth
+2.57%
P/S Ratio
2.02
Revenue / Employee
$1.40M
Employees
34,100
Market Cap
82.03B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 48.30B | 3.29B | 7.32% |
Dec 31, 2023 | 45.01B | -1.15B | -2.50% |
Dec 31, 2022 | 46.16B | -226.00M | -0.49% |
Dec 31, 2021 | 46.39B | 3.87B | 9.09% |
Dec 31, 2020 | 42.52B | 16.37B | 62.62% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
SAP SE | 35.89B |
Siemens Aktiengesellschaft | 78.30B |
Deutsche Telekom AG | 120.55B |
Allianz SE | 109.02B |
Rheinmetall AG | 10.67B |
Siemens Energy AG | 38.39B |
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 62.33B |
Deutsche Bank Aktiengesellschaft | 30.07B |
Bristol-Myers Squibb Company News
- 4 days ago - Bristol-Myers Squibb: Buy Before The Market Realizes Its Folly - Seeking Alpha
- 5 days ago - Insider Decision: David V Elkins Offloads $2.65M Worth Of Bristol-Myers Squibb Stock - Benzinga
- 5 days ago - Alexandria Real Estate Equities, Inc. Named One of the World's Most Trustworthy Companies by Newsweek for the Second Consecutive Year - Benzinga
- 6 days ago - Bristol-Myers Squibb: Not As Cheap As It Might Seem - Seeking Alpha
- 11 days ago - Bristol Myers Squibb Presents Real-World Outcomes of Camzyos (mavacamten) Across Four Continents at the European Society of Cardiology (ESC) Congress 2025 - Benzinga
- 12 days ago - Bristol Myers Squibb to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference - Wallstreet:Online
- 16 days ago - Bristol Myers Squibb to Present New Clinical and Real-World Data at the European Society of Cardiology Congress 2025 - Wallstreet:Online
- 19 days ago - Final Trades: ServiceNow, Bristol Myers and Live Nation - CNBC